• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组人粒细胞集落刺激因子可减轻中性粒细胞减少的脓毒症患者的炎症反应。

Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia.

作者信息

Ishikawa K, Tanaka H, Matsuoka T, Shimazu T, Yoshioka T, Sugimoto H

机构信息

Department of Traumatology, Osaka University Medical School, Japan.

出版信息

J Trauma. 1998 Jun;44(6):1047-54; discussion 1054-5. doi: 10.1097/00005373-199806000-00018.

DOI:10.1097/00005373-199806000-00018
PMID:9637161
Abstract

OBJECTIVE

The objective of this study was to determine the effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) administration in septic patients with neutropenia.

METHODS

Twenty consecutive septic patients were administered rhG-CSF subcutaneously (2 microg x kg(-1) x d(-1)) for 5 days (group G). They were compared with 14 septic patients treated earlier without rhG-CSF (group N). All patients in both groups met the criteria of total leukocyte count (TLC) less than 5,000/mm3 and C-reactive protein (CRP) more than 10 mg/dL. Changes in TLC, absolute neutrophil count (ANC), CRP, respiratory index (RI), Acute Physiology and Chronic Health Evaluation (APACHE) II score, and Goris's Multiple Organ Failure (MOF) index were evaluated. In addition, nucleated cell count (NCC), differentiation in bone marrow aspiration, neutrophil phagocytic and bactericidal activity, serum concentrations of interleukin-6 (IL-6) and IL-8 as inflammatory markers, and plasma concentration of leukocyte elastase (LE) as an indicator of the tissue injury were evaluated in group G.

RESULTS

In group G, TLC, ANC, NCC, and neutrophil functions increased significantly, whereas CRP, IL-6, and IL-8 decreased reciprocally. There was no deterioration of LE and RI. Consequently, the APACHE II score and MOF index improved. In group N, however, CRP showed no change concomitant with the APACHE II score and MOF index.

CONCLUSION

Administration of rhG-CSF attenuates inflammatory responses without inducing tissue injury in septic patients with neutropenia.

摘要

目的

本研究旨在确定重组人粒细胞集落刺激因子(rhG-CSF)对脓毒症伴中性粒细胞减少患者的影响。

方法

连续20例脓毒症患者皮下注射rhG-CSF(2微克×千克⁻¹×天⁻¹),共5天(G组)。将他们与14例早期未接受rhG-CSF治疗的脓毒症患者(N组)进行比较。两组所有患者均符合白细胞总数(TLC)低于5000/mm³和C反应蛋白(CRP)高于10mg/dL的标准。评估TLC、绝对中性粒细胞计数(ANC)、CRP、呼吸指数(RI)、急性生理与慢性健康状况评分系统(APACHE)Ⅱ评分以及戈里斯多器官功能衰竭(MOF)指数的变化。此外,对G组患者还评估了有核细胞计数(NCC)、骨髓穿刺中的分化情况、中性粒细胞吞噬和杀菌活性、作为炎症标志物的白细胞介素-6(IL-6)和IL-8的血清浓度,以及作为组织损伤指标的白细胞弹性蛋白酶(LE)的血浆浓度。

结果

G组中,TLC、ANC、NCC和中性粒细胞功能显著增加,而CRP、IL-6和IL-8则相应降低。LE和RI没有恶化。因此,APACHEⅡ评分和MOF指数有所改善。然而,在N组中,CRP没有变化,同时APACHEⅡ评分和MOF指数也未改变。

结论

在脓毒症伴中性粒细胞减少的患者中,给予rhG-CSF可减轻炎症反应而不引起组织损伤。

相似文献

1
Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia.重组人粒细胞集落刺激因子可减轻中性粒细胞减少的脓毒症患者的炎症反应。
J Trauma. 1998 Jun;44(6):1047-54; discussion 1054-5. doi: 10.1097/00005373-199806000-00018.
2
Difference in the responses after administration of granulocyte colony-stimulating factor in septic patients with relative neutropenia.相对中性粒细胞减少的脓毒症患者使用粒细胞集落刺激因子后的反应差异。
J Trauma. 2000 May;48(5):814-24; discussion 824-5. doi: 10.1097/00005373-200005000-00004.
3
Granulocyte colony-stimulating factor ameliorates life-threatening infections after combined therapy with barbiturates and mild hypothermia in patients with severe head injuries.粒细胞集落刺激因子可改善重度颅脑损伤患者在巴比妥类药物与轻度低温联合治疗后的危及生命的感染情况。
J Trauma. 1999 Jun;46(6):999-1007; discussion 1007-8. doi: 10.1097/00005373-199906000-00004.
4
Granulocyte colony-stimulating factor (G-CSF) stiffens leukocytes but attenuates inflammatory response without lung injury in septic patients.粒细胞集落刺激因子(G-CSF)可使脓毒症患者的白细胞变硬,但能减轻炎症反应且不会导致肺损伤。
J Trauma. 2001 Dec;51(6):1110-6. doi: 10.1097/00005373-200112000-00016.
5
Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.危重病(包括脓毒症和脓毒性休克)患者血浆粒细胞集落刺激因子和粒细胞巨噬细胞集落刺激因子水平:与疾病严重程度、多器官功能障碍及死亡率的关系
Crit Care Med. 2000 Jul;28(7):2344-54. doi: 10.1097/00003246-200007000-00028.
6
Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial.对脓毒症新生儿给予重组人粒细胞集落刺激因子可诱导中性粒细胞增多,并增强中性粒细胞呼吸爆发和β2整合素表达。一项随机对照试验的结果
Eur J Pediatr. 1998 Jul;157(7):583-8. doi: 10.1007/s004310050884.
7
Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.人粒细胞集落刺激因子可能改善新生儿败血症合并中性粒细胞减少症的预后。
Pediatrics. 1997 Jul;100(1):E6. doi: 10.1542/peds.100.1.e6.
8
Cytokine profile during high-dose rhG-CSF therapy in severe congenital neutropenia.严重先天性中性粒细胞减少症患者大剂量重组人粒细胞集落刺激因子治疗期间的细胞因子谱
Am J Hematol. 1994 Jan;45(1):58-62. doi: 10.1002/ajh.2830450109.
9
Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.重组人粒细胞集落刺激因子治疗早产儿伴脓毒症和相对中性粒细胞减少症的随机、单盲、非安慰剂对照试验。
J Trop Pediatr. 2012 Feb;58(1):12-8. doi: 10.1093/tropej/fmr012. Epub 2011 Feb 4.
10
Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.初步报告:重组人粒细胞集落刺激因子(rhG-CSF)可能降低重度子痫前期相关中性粒细胞减少症患儿新生儿败血症的发生率。
Pediatrics. 1998 Nov;102(5):1107-11. doi: 10.1542/peds.102.5.1107.

引用本文的文献

1
Survivors of polymicrobial sepsis are refractory to G-CSF-induced emergency myelopoiesis and hematopoietic stem and progenitor cell mobilization.多微生物脓毒症幸存者对 G-CSF 诱导的紧急骨髓生成和造血干细胞及祖细胞动员反应不佳。
Stem Cell Reports. 2024 May 14;19(5):639-653. doi: 10.1016/j.stemcr.2024.03.007. Epub 2024 Apr 11.
2
The Effects of Granulocyte Colony-Stimulating Factor (G-CSF) in Pre-Clinical Models of Infection and Acute Inflammation.粒细胞集落刺激因子(G-CSF)在感染和急性炎症临床前模型中的作用
Sepsis (Boston). 1998;2(3):213-220. doi: 10.1023/A:1009829712638.
3
In canine bacterial pneumonia circulating granulocyte counts determine outcome from donor cells.
在犬细菌性肺炎中,循环粒细胞计数决定供体细胞的预后。
Transfusion. 2020 Apr;60(4):698-712. doi: 10.1111/trf.15727. Epub 2020 Feb 22.
4
Administration of signalling molecules dictates stem cell homing for in situ regeneration.信号分子的给药决定了干细胞归巢以实现原位再生。
J Cell Mol Med. 2017 Dec;21(12):3162-3177. doi: 10.1111/jcmm.13286. Epub 2017 Aug 2.
5
Toward improving mucosal barrier defenses: rhG-CSF plus IgG antibody.旨在改善黏膜屏障防御:重组人粒细胞集落刺激因子加免疫球蛋白G抗体。
Indian J Pediatr. 2006 Nov;73(11):1019-26. doi: 10.1007/BF02758311.
6
Perioperative recombinant human granulocyte colony-stimulating factor (Filgrastim) treatment prevents immunoinflammatory dysfunction associated with major surgery.围手术期重组人粒细胞集落刺激因子(非格司亭)治疗可预防与大手术相关的免疫炎症功能障碍。
Ann Surg. 2004 Jan;239(1):75-81. doi: 10.1097/01.sla.0000103062.21049.82.
7
Bactericidal activity response of blood neutrophils from critically ill patients to in vitro granulocyte colony-stimulating factor stimulation.重症患者血液中性粒细胞对体外粒细胞集落刺激因子刺激的杀菌活性反应。
Intensive Care Med. 2003 Mar;29(3):396-402. doi: 10.1007/s00134-002-1623-9. Epub 2003 Jan 23.
8
Colony-stimulating factors for the management of neutropenia in cancer patients.用于癌症患者中性粒细胞减少症管理的集落刺激因子。
Drugs. 2002;62 Suppl 1:1-15. doi: 10.2165/00003495-200262001-00001.
9
Granulocyte colony-stimulating factor improves deficient in vitro neutrophil transendothelial migration in patients with advanced liver disease.粒细胞集落刺激因子可改善晚期肝病患者体外中性粒细胞跨内皮迁移缺陷。
Clin Diagn Lab Immunol. 2002 Mar;9(2):433-9. doi: 10.1128/cdli.9.2.433-439.2002.
10
Adjunctive Therapies for Sepsis and Septic Shock.脓毒症和脓毒性休克的辅助治疗
Curr Infect Dis Rep. 1999 Aug;1(3):224-229. doi: 10.1007/s11908-999-0023-5.